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Purpose:  Recent  ﬁndings  indicate  the  signiﬁcant  contribution  of  urokinase  and  urokinase  receptor  (uPA
and  uPAR)  in  the  processes  of  nerve  regeneration,  however,  their  role  in  axonal  growth  and  branching  is
unclear.  Using  a 3D  model  of  mouse  Dorsal  Root  Ganglia  (DRG)  explants,  differentiated  into  neurons  Neuro
2a cells  and  transgenic  mice  lacking  the  urokinase  gene,  we  studied  the  involvement  of  the uPA/uPAR
system  in  the  neural  cell  migration,  neurite  outgrowth,  elongation  and  branching.
Results: uPA  and  uPAR  are  expressed  in  the  growth  cones  of axons.  Using  an  ex  vivo  model  of  DRG  explants
in  Matrigel  we have  found  that  uPA  inhibition  attenuates  neural  cell  migration  and  axonal  growth,  point-
ing  to  an important  role  of  urokinase  in these  processes.  Apparently,  uPA  mediates  its effects  through
its  speciﬁc  receptor  uPAR:  anti-uPAR  antibody,  which  blocks  the uPA  binding  to  uPAR,  stimulates  axon
branching  and  attenuates  neural  cell  migration  from  DRG  explants.  Simultaneous  inhibition  of  uPA and
uPAR  almost  completely  prevents  the  axonal  outgrowth  from  explants  into  the  Matrigels.  Experiments
in  vitro  using  Neuro  2a cells  differentiated  into  neurons  demonstrate  that  administration  of exogenous
uPA  increases  the  neurite  growth  rate (elongation),  most  likely  via  the  interaction  of uPA  with  uPAR.
Blocking  of  uPAR  stimulates  neurite  formation  and  enhances  branching  of  preexisting  neurites.  The
results  obtained  on  DRG  explants  from  transgenic  mice  lacking  uPA  gene  support  the assumption  that
uPA  stimulates  neurite  growth  via  uPA/uPAR  interaction  and  uPAR  role  in  axons  branching  and  neural
cell  migration.
Conclusions:  The  uPA/uPAR  system  plays  an  essential  role in neural  cell  migration,  axonal  growth  and
branching.
© 2016  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the CC. Introduction
The urokinase system is important for plasminogen activation
nd ﬁbrinolysis. The urokinase system comprises urokinase (uPA),
 serine protease that cleaves and activates inactive zymogen plas-
inogen to the active endopeptidase plasmin, and uPAR—uPA high
fﬁnity receptor. uPA consists of the receptor-binding N-terminal
pidermal growth factor-like domain (GFD), C-terminal proteolytic
omain and kringle domain. GFD domain is responsible for a highly
peciﬁc uPA binding to uPAR, while kringle maintains uPA-uPAR
Abbreviations: uPA, urokinase-type plasminogen activator, urokinase; uPAR,
rokinase receptor; DRG, Dorsal Root Ganglia.
∗ Corresponding author.
E-mail address: rkseniya@mail.ru (K. Rubina).
ttp://dx.doi.org/10.1016/j.ejcb.2016.05.003
171-9335/© 2016 The Authors. Published by Elsevier GmbH. This is an open access artic
.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
complex stabilization and its interaction with the extracellular
matrix. uPAR contains three homologous domains and is anchored
to the plasma membrane via the GPI-anchor (Collen, 1999; Blasi
and Sidenius, 2010). GPI-anchor provides high lateral mobility
within the membrane which is important for uPAR functioning
since it mediates the uPA/uPAR complex clustering at the leading
edge of migrating cells and facilitates local proteolysis (Bruneau
and Szepetowski, 2011). uPA binds to uPAR on the cell surface
(Estreicher et al., 1989, 1990; Farias-Eisner et al., 2000), and this
binding increases uPA activity (Vassalli et al., 1985). uPA in associ-
ation with uPAR triggers extracellular matrix proteolysis as well as
some other cellular processes (Goncharova et al., 2002; Menshikov
et al., 2006a; Menshikov et al., 2006b; Kjoller and Hall, 2001).
Accumulating evidence indicates that the urokinase system
is implicated in cardiovascular functioning. Previously, we have
shown that uPA and uPAR are expressed in migrating and
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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roliferating vascular cells and are involved in the pathogenesis
f cardiovascular diseases including atherosclerosis and resteno-
is (Poliakov et al., 1999; Stepanova et al., 1999; Mukhina et al.,
000; Plekhanova et al., 2001, 2009). uPA promotes vascular cell
igration and proliferation via uPA-mediated plasmin proteoly-
is leading to matrix degradation and growth factor activation
Blasi and Sidenius, 2010; Blasi and Carmeliet, 2002). However, uPA
as non-proteolytical functions that are implemented through the
apid activation of intracellular signaling such as serine and tyro-
ine phosphorylation (Dent et al., 1993; Endo et al., 1998), and RhoA
nd Rac1 activation (Kjoller and Hall, 2001). In vivo local increase in
rokinase content upon recombinant uPA administration or plas-
id  transfection greatly promotes neointima formation and inward
rterial remodeling via the stimulation of the vascular cell migra-
ion, of their proliferation and of their phenotypic transformation
Poliakov et al., 1999; Stepanova et al., 1999; Mukhina et al., 2000;
lekhanova et al., 2001, 2009).
Despite the functional differences between the blood vessels
nd the nerves certain structural similarities could be observed
Carmeliet, 2003; Hawkins and Seeds, 1989). Vessels and nerves
re aligned along each other and often have the same branching
ircuits in tissues. Recent ﬁndings indicate that the similarities
etween the nervous and the vascular system extend to the
olecular level: guidance molecules and intracellular signaling
hat control the growing axons and their branching are used by
essels to regulate angiogenesis (Carmeliet, 2003; Hawkins and
eeds, 1989). It is known that angiogenic growth factors such
s vascular growth factor (VEGF), platelet-derived growth factor
PDGF-BB), hepatocyte growth factor (HGF) and matrix metal-
oproteases (MMPs) that play a substantial role in angiogenesis
lso regulate axon growth and neuron survival (Carmeliet, 2003).
n the other hand, such neurotrophins as nerve growth factor
NGF), glial cell line-derived neurotrophic factor (GDNF), brain-
erived neurotrophic factor (BDNF) and membrane receptors such
s tropomyosin receptor kinase B TrkB, NOTCH1 and Neiropilin-
 are required for endothelial tip cell guidance during the blood
essel growth (Carmeliet, 2003). Numerous studies provide evi-
ence for the presence of plasminogen activators in neurons and
heir involvement in phenotypic change and the regulation of axon
utgrowth, as well as their involvement in pathological conditions
Mukhina et al., 2000; Pittman et al., 1989; Sumi et al., 1992; Dent
t al., 1993). It has been previously shown that uPAR expression is
ssential for the normal development of subpopulations of GABAer-
ic neurons, since in mice with null mutation in the uPAR gene there
s a selective loss of GABAergic interneurons in the brain cortex.
oreover, uPAR function may  inﬂuence the migration and differ-
ntiation of parvalbumin-containing interneurons, both pre- and
ostnatally (Eagleson et al., 2005). uPAR mutation leads to epilepsy
nd an autistic phenotype in mice (Ndode-Ekane and Pitkänen,
013). While in humans nucleotide polymorphism in PLAUR gene
nd its alternative ligand in the brain SRPX2 (Sushi repeat pro-
ein, X-linked 2) result in a high risk of autism disorders as well
s other brain diseases (stroke and brain trauma, autism, multi-
le sclerosis, Alzheimer’s disease, cerebral malaria, HIV-associated
eukoencephalopathy and encephalitis) (Lino et al., 2014). The
forementioned data make the studies of uPAR important in
nderstanding the mechanisms of development and functioning
f neurons, as well as pointing to a possible contribution of uPAR
o the pathology of the central nervous system.
In vitro studies showed that plasminogen activators are secreted
y cultured peripheral neurons and Schwann cells (Krystosek and
eeds, 1984; Krystosek et al., 1988; Pittman et al., 1989). In murine
mbryonic DRG and in the ventral motor neurons in vivo, the
omponents of the urokinase system are activated during axonal
utgrowth and projection towards their peripheral targets (Franco
t al., 2006; Dent et al., 1993; Seeds et al., 1996). Furthermore,ell Biology 95 (2016) 295–310
in murine peripheral nerves, regenerating after a sciatic nerve
cruh, the maximal axonal outgrowth correlates with a signiﬁ-
cant increase in the mRNA expression of plasminogen activators
(Siconolﬁ and Seeds, 2001). Lino and co-authors (Lino et al., 2014)
showed that during neuritogenesis uPA activates focal adhesion
kinase, which is involved in the reorganization of the cytoskeleton
and cell locomotion. Since uPAR is a GPI-anchored protein lacking
a transmembrane part, signal transduction upon uPA binding to
uPAR proceeds via lateral interaction with membrane co-receptors
including integrins 5 and 1 (Lino et al., 2014). Despite the data
indicating the importance of uPA-uPAR system in neurogenesis, the
role of uPA and uPAR in axon growth and branching is still unclear.
In the present study we addressed the role of the uPA-uPAR
system using in vitro and ex vivo neuronal testing systems, which
reﬂect the biological features of regeneration and repair at the
whole-organism level. To identify the molecular mechanisms
underlying these processes we used 3-dimensional (3D) model of
neurite outgrowth from DRG explants from wild type and trans-
genic mice lacking the urokinase gene as well as neuroblastoma
Neuro 2a cell line. In the present study we  demonstrate that uPA
and uPAR are essential for the regulation of axonal growth and
branching as well as of neural cell migration.
2. Materials and methods
2.1. Antibodies and reagents
The following primary antibodies were used: rat anti-uPAR
(cat# MAB531, RD Systems), rabbit anti-NF200 recognizing axons
neuroﬁlaments (Abcam), rabbit anti-uPA (Abcam). Secondary
antibodies were anti-goat and anti-rabbit AlexaFluor® 488 or
AlexaFluor® 594 (Molecular Probes). Rabbit anti-GAPDH (Santa
Cruz) antibody was used in western blotting for protein loading
control; HRP-conjugated donkey anti-rabbit IgG (Jackson Immuno-
Research Laboratories) was  used as a secondary antibody for
western blotting. The chemicals used for western blotting were
from Bio-Rad, and the buffers for immunoﬂuorescence were
purchased from Gibco. Trypsin and Hank’s buffer (HBSS) was pur-
chased from Gibco. Selective uPA inhibitor (BC 11 hydrobromide)
at IC50 8,2 M was purchased from Tocris Bioscience. DNA Ladder
(GeneRuler 50 bp DNA Ladder) and 6X DNA Loading Dye for agarose
electrophoresis were purchased from Thermo Scientiﬁc; low-melt
agarose and ethidium bromide were obtained from BioRad.
2.2. Animals and ethics statement
This study was  completed in accordance with the European
convention for the Protection of Vertebrate Animals used for
Experimental and other Scientiﬁc purposes (ETS 123). All routine
procedures, including animal housing and care were conducted in
accordance with the revised Appendix A to ETS 123. The study was
evaluated by the local ethical committee. We used 4–5 week old
male mice lacking the uPA gene (originally derived from C57/B6
mice by group of Carmeliet from the FIRC Institute of Molecular
Oncology (Milan, Italy)) (Carmeliet et al., 1994) and wild type C57
male mice of matching age as a control. Mice strains were used for
dorsal root ganglia (DRG) explants. Before DRG  withdrawal ani-
mals were anesthetized with a lethal dose of isoﬂurane IsoFlo®
(isoﬂurane, USP).
2.3. Dorsal Root Ganglia explantsFor the experiment we used male mice 4–5 weeks old. Mice
were anesthetized with a lethal dose of isoﬂurane IsoFlo® (isoﬂu-
rane, USP) in a gas chamber. Other animals were exsanguinated by
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ecapitation. The spinal ganglia were isolated under aseptic condi-
ions using sterile surgical instruments for small laboratory animals
nder a stereomicroscope Olympus SZX16. The isolated tissue was
mmediately placed in a Petri dish containing sterile pre-chilled
ank’s buffer HBSS and transferred into the laminar ﬂow hood.
ll further manipulations were performed in sterile conditions.
RGs were washed in sterile HBSS, placed in an 8-well cham-
ered borosilicate coverglass (Lab-Tek®, cat# 155411) and covered
mmediately with a 60 l drop of Matrigel (BD MatrigelTM Base-
ent Membrane Matrix) for 3D tissue explant culture or in plates.
or 2D DRG cultures, plates were covered with cold Matrigel; after
atrigel polymerization DRGs were placed on Matrigel surface (see
upplementary Fig. S1 in the online version at DOI: 10.1016/j.ejcb.
016.05.003). Wells were ﬁlled with a warm RPMI culture medium.
he culture medium was replaced every 5 days. DRG explants were
ultures in 5% CO2 incubator at 37 ◦C.
For the suppression of endogenous uPA in DRG explants we
dded a speciﬁc uPA inhibitor BC 11 hydrobromide (Tocris Bio-
cience) at the ﬁnal concentration IC50 8.2 M to the Matrigel.
o block uPAR, antibodies blocking the receptor-ligand interac-
ion (anti-uPAR antibody, R&D Systems) were used. For complete
nhibition of uPA and uPAR, both blocking agents were mixed with
atrigel before placing the DRG explants and subsequent Matrigel
olymerization; blocking agents were also added to the culture
edium to equilibrate the system. The medium, containing the
locking agents, was changed to a fresh one every 5 days.
Visualization and imaging was carried out daily for 14 days using
ight microscopy (Zeiss Axoivert 2000) at low magniﬁcation. Image
rocessing (neurite counting, measurements of neurite length, as
ell as the number of cells, that migrated from the explants) was
erformed using automated image analysis program (MetaMorph
rogram, Molecular Devices, PA, USA). Tissue explants from at least
 wild type and 3 uPA-deﬁcient mice were included in each exper-
ment. The results of at least three independent experiments are
resented.
.4. 3-Dimensional immunoﬂuorescent staining of DRG
To prevent Matrigel depolymerization all procedures were
arried out at 37 ◦C. For 3-dimensional multicolor immunoﬂuo-
escence staining, 8-well plates were removed from the incubator
nd washed with warm HBSS (Gibco). All solutions were prepared
n HBSS. The samples were ﬁxed with 4% paraformaldehyde for
4 h (Panreac). After ﬁxation, the samples were washed in HBSS
or 24 h. Next, the samples were permeabilized with 1% Triton X-
00 (Triton® X-100, Peroxide Free, Panreac) for 24 h and washed
n HBSS buffer for 24 h. Further, the samples were treated with 5%
SA (Sigmaaldrich), containing 1% Triton X-100, for 24 h to block
on-speciﬁc binding. Then the samples were washed in HBSS con-
aining 1% Triton X-100 for 24 h and incubated in the solution of
he ﬁrst antibodies for 24 h. After that the samples were washed in
BSS for 24 h, incubated in the solution of the second antibodies,
nd conjugated with ﬂuorochrome AlexaFluor® 594 (1:500, Molec-
lar Probes). Finally, the samples were placed in HBSS, containing
API (Sigmaaldrich, 1:10000) to visualize nuclei and incubated for
4 h. To prevent contamination, the samples were stored in HBSS
olution containing 0,001% NaN3. The number of migrating cells
as evaluated after DAPI staining using confocal microscopy with
ubsequent analysis with an automated image analysis program
MetaMorph Program, Molecular Devices, PA, USA).
.5. 3-Dimensional confocal imaging of DRGImages were acquired by confocal laser scanning microscopy
sing a microscope system (TCS SP5, Leica) equipped with a Plan-
po ×10, 1.40 NA objective and 543-Argon lasers lines. Imaging wasell Biology 95 (2016) 295–310 297
performed at room temperature using Leica Type F immersion oil.
DAPI and AlexaFluor® 594 ﬂuorescence were sequentially excited
using lasers with wave lengths of 405 and 594, respectively. All
images were captured with the same confocal gain and offset set-
tings. Images (1024 × 1024 pixels) were saved as TIFF ﬁles in Leica
LAS software and then processed in Photoshop (version CS5, Adobe)
to generate ﬁgures. Images are presented as overlap of red and blue
staining. The results of at least three independent experiments are
presented.
2.6. Cell culture
Mouse Neuro 2a neuroblastoma (N2a) cell line (ATCC®
CCL-131TM) was  cultured in full growth medium containing
DMEM (Hyclone) with high glucose, 10% FBS (Gibco), 1× MEM
Non-Essential Amino Acids Solution (Gibco) and 1× Antibiotic-
antimycotic solution (Gibco). Cells were plated at a concentration
of 1 × 105 cells/ml. Cells were enrolled in the experiments before
the 20th passage. Differentiation of Neuro 2a cells into neurons was
induced by 24 h cell deprivation with media containing 1% FBS: full
growth medium was  replaced by DMEM,  1× MEM  Non-Essential
Amino Acids Solution (Gibco), 1× Antibiotic-Antimycotic (Gibco)
and 1% FBS (Hyclone) for 24 h. 1–3 days later, the differentiated cul-
tures of neurons were used for experiments and western blotting
analyses.
To evaluate the effects of uPAR on neurite branching, N2a cells
were seeded onto cell culture dishes in a rare monolayer. The
cells were allowed to adhere and, after uPAR blocking, antibodies
(25 g/ml) were added to the culture medium for 24 h. As a control
we used non-immune IgG in an equivalent concentration. Using a
light microscope we analyzed neurites in the 6 ﬁelds of view, where
cells were plated in a low-concentration and had no contacts with
one another.
2.7. Tissue lysates and western blotting
DRG were placed in a mortar and immediately frozen using liq-
uid nitrogen. After nitrogen evaporation, the tissue samples were
ground by a pounder. After that, the samples were transferred to
Eppendorf tubes and incubated in a lysis buffer (1 g of tissue per
1 ml  of lysis buffer containing 150 mM NaCl 1% NP-40, 50 mM Tris,
pH 8,0 and protease inhibitor cocktail (Pierce)). After incubation in
the lysis buffer on ice for 20 min, the samples were pipetted at least
30 times and pelleted at 15,000 rpm for 10 min. Supernatants were
transferred to the new tubes and their protein concentration was
measured using the Bio-Rad Protein Assay (Bio-Rad Laboratories)
with bovine serum albumin (BSA) as a standard.
Samples were diluted to equal protein concentration in a
Laemmli buffer containing -mercaptoethanol, heated for 10 min
at 90 ◦C, electrophoresed in 10% SDS/polyacrylamide gel and elec-
troblotted onto nitrocellulose membranes (Immobilon, Millipore).
Kaleidoscope Prestained Standards (Bio-Rad Laboratories) were
used as molecular weight markers. After rinsing in Tris-buffer saline
(TBS: 150 mM NaCl, 50 mM Tris/HCl, pH 7.4), membranes were
pre-blocked in an incubation buffer (TBS containing 5% (w/v) of
delipidated milk and 0.5% Tween 20; TBSM) for 120 min. Mem-
branes were incubated with the speciﬁc primary antibody for 24 h
at 4 ◦C, washed with TBSM, and then incubated with secondary
antibodies conjugated with peroxidase for 1 h. Membranes were
ﬁnally washed in TBS containing 0.5% Tween 20 and visualized
using SuperSignal West Pico Chemiluminescent Substrate (Thermo
Scientiﬁc) and ChemiDocTM XRS + System (BioRad) for blot imaging
and analysis.
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.8. Neuro 2a immunoﬂuorescent staining
N2a cells were seeded into the wells of the Nunc® Lab-Tek®
hamber SlideTM system at a low concentration (2 × 104/ml) in a
ull growth medium; 24 h later, the cells were differentiated into
he neurons as described above. 24 h later, the slides were removed
rom the incubator and washed with warmed HBSS for 10 min.
ells were ﬁxed in 4% formaldehyde, incubated with the ﬁrst and
econd antibodies and then washed in HBSS. Staining of N2a cells
or intracellular uPA was performed in permeabilizing conditions
sing Triton X-100 incubation (10 min, 0,1% in HBSS). The nuclei
ere counterstained with DAPI. Images were acquired by a con-
ocal laser scanning microscopy system (TCS SP5, Leica) equipped
ith a Plan-Apo x60, 1.40 NA oil objective and 488- and 543-Argon
asers lines. Imaging was performed at room temperature using
eica Type F immersion oil. DAPI, AlexaFluor® 488 and AlexaFluor®
94 ﬂuorescence were sequentially excited using lasers with wave-
engths of 405 (DAPI), 488 (AlexaFluor® 488) and 594 (AlexaFluor®
94). All images were captured with the same confocal gain and
ffset settings.
Images (2048 × 2048 pixels) were saved as TIFF ﬁles in Leica LAS
oftware and then compiled in Photoshop (version CS5, Adobe). The
esults of at least three independent experiments are presented.
.9. HEK293 transfection
To obtain murine uPA, HEK293 cells (ATCC® CRL-1573TM) were
ransfected with pcDNA3.1 (Life Technologies) vector, containing
he full length of mouse uPA (pcDNA3.1-uPA). For a control we  used
onditioned media from HEK293 cells transfected with pcDNA3.1,
ontaining the antisense sequence of luciferase. Cells were cultured
n DMEM (Hyclone), supplemented with 10% FBS (Hyclone), 1×
ntibiotic-antimycotic solution (Gibco). For plasmid transfection
ipofectamine2000 (Life Technologies) was used, and the transfec-
ion was carried out according to the manufacturer’s protocol. After
2 h, the conditioned medium from the transfected cells was col-
ected, centrifuged to pellet debris, and the concentration of uPA
as determined in the medium from the uPA-transfected and the
ontrol cells using ELISA Cell Sciences (cat# CSI19903A). The ﬁnal
oncentration of uPA in conditioned media for further experiments
as 10 ng/ml. Bovine serum albumin (BSA) was added to the con-
rol media for system equilibrating.
.10. Neuritogenesis analysis and neurite growth pattern
To reveal the role of the urokinase system in neurite growth
atterning we used uPAR blocking antibodies, exogenous uPA and
 selective uPA inhibitor. The differentiated cultures of N2a cells
ere plated onto 24-well plates in a concentration of 2 × 104
ells/ml. Blocking uPAR antibodies (R&D Systems) were used in
 concentration of 25 g/ml, and non-immune IgG in the corre-
ponding concentration were used as a control. To obtain mouse
PA, we used the conditioned medium from HEK293 cells that had
een previously transfected with murine pcDNA3.1-uPA or control
ector pcDNA3.1. The ﬁnal uPA concentration in the conditioned
edium enrolled in experiments was 10 ng/ml. For uPA inhibit-
ng, we used the speciﬁc uPA inhibitor BC 11 hydrobromide at IC50
.2 M.  Neurite outgrowth was evaluated using a phase-contrast
ight microscope (Axiovert 2000, Zeiss Ltd.) with a dry 20× objec-
ive. The growing process was considered as a neurite if its length
xceeded the diameter of the cell body. The effects of uPAR on the
rowth rate and branching of the neurites were evaluated after
4 h according to three criteria: (1) the formation of the new pro-
esses/outgrowths (e.g., the number of processes in the cell); (2) the
umber of branch points in the forming neurite (the existence of
 branching point was established if there was a branching of twoell Biology 95 (2016) 295–310
or more independent neurites with visible thickening at the site
of the branching); (3) the average neurite length. Every cell was
subjected to neurite length analysis that was carried out using an
automated image analysis program (MetaMorph Program, Molec-
ular Devices, PA, USA) with the same parameter set for all samples.
The amount of neurites/processes, neurite branching and the length
of neurites were evaluated on 200 cells per well in 6 randomly cho-
sen ﬁelds. The results of at least three independent experiments are
presented.
2.11. Impedance measurement with the xCELLligence system
xCELLligence was  used to evaluate the neurite outgrowth. The
xCELLigence system (Roche, USA) monitors cellular events in real
time and measures the electrical impedance across microelec-
trodes integrated into the bottom of E-Plates. The impedance
measurement provides quantitative information on cell adhesion,
cell number and viability. The differentiated neuroblastoma cells
were removed from the culture dishes by trypsinization and pel-
leted by centrifugation. N2a cells were resuspended to the ﬁnal
concentration of 1 × 104 cells/ml in HEK293 conditioned medium
containing uPA (10 ng/ml) or in conditioned medium from the con-
trol HEK cells. 1 × 104 of N2a cells in 100 l media were seeded
in E-plate wells after background measurement. The background
measurement of the E-plates was  performed in 100 l of DMEM
with 1% FBS for 30 min. The system was transferred to a CO2 incu-
bator. The E-plates were placed into the Real-Time Cell Analyzer
(RTCA) station where the cell index was  continuously monitored
at 15 min  intervals for 74 h. The impedance measurement exper-
iment was  repeated six times. The analysis of real-time data was
performed with RTCA Software 1.2 (Roche, USA).
2.12. Murine uPAR overexpression and downregulation in N2a
cells
To suppress native uPAR expression we  used a commercially
available plasmid vector encoding shRNA (uPAR shRNA Plasmid,
Santa Cruz, sc-36782-SH). For overexpression we  used a pN1
vector encoding full-length murine uPAR DNA (pN1-uPAR). The
vector was obtained from Dr. N. Sidenius of the FIRC Institute
of Molecular Oncology. Cell transfection was  performed accord-
ing to the Lipofectamine2000 (Life Technologies) protocol. After
transfection, the cells were cultured for 8 weeks in a complete
medium containing selective antibiotics: puromycin for sh-uPAR
(at 2 g/ml, Sigmaaldrich) and G418 for pN1-uPAR (at 200 g/ml,
Sigmaaldrich). Changes in mRNA expression were assessed using
Real Time PCR (RT-PCR).
2.13. Quantitative real-time polymerase chain reaction analysis
(RT-PCR)
The RNeasy® Mini Kit (Qiagen, Germany) was used for the
extraction of total RNA from the DRG explants of wild type mice
and uPA-deﬁcient mice, as well as from N2a cells transfected
with pN1-uPAR, shRNA-uPAR or the control vector. For cDNA
preparation 1 g of total RNA was  used. The cDNA synthesis
was carried out using SuperScript® III First-Strand Synthesis
SuperMix for qRT-PCR (Thermo Fisher Scientiﬁc). The concen-
tration of undiluted cDNA in qPCR reaction volume was 8%. To
select the speciﬁc sequence primer, Primer-BLAST software was
used following by pre-validation of the primer speciﬁcity with
OligoAnalyzer 3.1 (available online at www.https://eu.idtdna.
com/calc/analyzer). Further primers for murine uPAR and -actin
(used as an endogenous control gene) were obtained from Evro-
gen (Russia): uPAR-forward 5′-CGCCACAAACCTCTGCAAC-3′,
uPAR-reverse 5′-CTCTGTAGGATAGCGGCATTG-3′, -actin-
E. Semina et al. / European Journal of Cell Biology 95 (2016) 295–310 299
Fig. 1. uPA and uPAR affects neurites outgrowth and cell migration from DRG explants ex vivo. (A) After 14 days in Matrigel culture, 3D explants were stained with antibody
against NF200 to visualize axons. The nuclei of cells migrated from DRG to the Matrigel were counterstained with DAPI. In control numerous radially growing axons as well
as  a great number of cells migrating from DRG explant could be observed. uPAR blocking by antibodies (anti-uPAR) changed the trajectory of the growing axons from a
straight line to a wavy line (arrows in the ﬁgure), accompanied by the increased axonal branching. In addition, anti-uPAR reduced the migration of cells from explant to
Matrigel. uPA inhibition (uPA Inh, BC 11 hydrobromide, IC50 8,2 M)  led to the reduction of the number of the growing axons, a decrease in their growth rate and a distorted
growth trajectory (arrows in the ﬁgure). Complete inhibition of both uPA and uPAR caused nearly total suppression of neurite outgrowth from DRG explants to Matrigel.
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o  control, #p < 0.01 compared to control, N = 6. (C) Assessment of the relative avera
 < 0.001 compared to control. Reproducible results of six independent experiment
orward 5′-AGTGTGACGTTGACATCCGTA-3′, -actin-reverse
′-GCCAGAGCAGTAATCTCCTTCT-3′. The primers’ speciﬁcity was
onﬁrmed initially by an analysis of melting curves (raw data in
upplementary Fig. S2 in the online version at DOI: 10.1016/j.ejcb.
016.05.003) and then followed by agarose gel electrophoresis to
erify the production of a single gene-speciﬁc product (Fig. 6A).
he raw data of RT-PCR analysis of uPAR mRNA expression was
erformed using the qPCRmix-HS SYBR (Evrogen, Russia) on DT-96
eal-time PCR device (DNA-technology, Russia). The raw data of
T-PCR analysis of uPAR expression are presented in Supplemen-
ary Fig. S3 in the online version at DOI: 10.1016/j.ejcb.2016.05.lls outside the DGR explants. Data are shown as mean ± SEM, *,**p < 0.05 compared
gth of axons emerging from DGRs into Matrigels. Data are shown as mean ± SEM, *
resented.
003. The thermal cycling program for template denaturation, uPAR
and -actin primers annealing and primer extension was 94◦ C for
15 s, 62◦ C for 15 s and 72◦ C for 20 s for 40 cycles, correspondingly.
A relative transcript level of uPAR was  calculated using the 2−Ct
method.
2.14. Statistical processing of resultsData from all experiments are presented as mean ± SEM. Com-
parisons between multiple groups were performed using the
One-Way ANOVA and the Student-Newman-Keuls Test for mul-
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Fig. 2. Expression of uPA and uPAR on the axon growth cones in differentiated N2a cells in vitro. (A) Double immunoﬂuorescent staining of N2a cells for uPAR and axon
visualization (NF200). Nuclei were counterstained with DAPI. Arrows point to the growth cones. Inserts on the right depict the growth cones with higher magniﬁcation. Bars
10  m.  (B) Cells were permeabilized with 0.1% Triton X-100 and stained with antibodies against uPA (red) and uPAR (green). Nuclei were counterstained with DAPI. Arrows
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iple comparisons. Single comparisons were made using Student’s
-test. A value of p < 0.05 was considered statistically signiﬁcant.
he statistical analysis was performed using STATISTICA software.
. Results
.1. Simultaneous inhibition of uPA and uPAR abrogates axon
utgrowth and cell migration from DRG explants
To study the effects of uPA and uPAR on neural cell migra-
ion and neuritogenesis we isolated dorsal root ganglia (DRG) from
ild-type C57/B6 mice and cultured them inside the Matrigel drops
x vivo. Supplementary Fig. S1 in the online version at DOI: 10.
016/j.ejcb.2016.05.003 shows that in contrast to the 3D DRG cul-
ure, where cell migration and neurites’ outgrowth from DRG into
he Matrigel could be evaluated, no neurite outgrowth could be
etected in the 2D DRG culture. Thus, the 3D explant DRG culture is
 more relevant model than a 2D culture since it adequately reﬂects
he in vivo biological features of regeneration, i.e. the outgrowth of
eurites and the migration of neural cells.
For the selective suppression of endogenous uPA in DRG
xplants we added a speciﬁc uPA inhibitor BC 11 hydrobromide.
o block uPAR, antibodies which block the binding of uPA to itsiﬁcation. Bars 10 m.  Reproducible results of three independent experiments are
 is referred to the web  version of this article.)
receptor uPAR were used. For complete inhibition of uPA and uPAR,
both blocking agents were mixed with Matrigel before placing the
DRG explants and Matrigel polymerization. On the 14th day the
DRG explants in 3D Matrigel culture were stained with antibod-
ies recognizing mature axons (NF200) and with DAPI to visualize
the nuclei of migrating cells. 3D-Matrigels with DRG explants were
analyzed using a scanning confocal imaging microscope.
In control DRG explants, axons grew in a radial manner from
the ganglia with minimal branching (Fig. 1A, C). Also, a large num-
ber of cells migrated outwards from the explants into the Matrigels
(Fig. 1B). The suppression of endogenous urokinase (uPA Inh) sub-
stantially abrogated the axonal growth (Fig. 1A, C): the length
of axons was decreased while their normal growing trajectory
was impaired (arrows in Fig. 1A). Also uPA inhibition signiﬁcantly
reduced the number of cells that migrated from DRG explants to
the Matrigels (Fig. 1B). Supplementary materials contain videos of
stereomicroscopy images obtained using 3D DRG explants and pre-
sented in Fig. 1A (Video S1–S4 in the online version at DOI: 10.1016/
j.ejcb.2016.05.003).
uPAR blocking led to alteration of the normal axonal growth
trajectory and increased branching (arrows in Fig. 1A), however,
it had no statistically signiﬁcant effect on axons’ length (Fig. 1C).
The number of the growing axons was also reduced, as well as the
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Fig. 3. uPAR blocking in neurons results changes in N2a cell morphology. Differentiated N2a cells were plated at a low cell density in culture dishes. After the cells adhered,
uPAR  blocking antibodies (anti-uPAR) or control IgG were added. After 24 h the cells were visualized using a light microscope (A). The number of processes, the number
of  branches and the length of neurites were calculated in at least 6 ﬁelds of view in each well (3 wells with anti-uPAR and 3 wells with IgG). The statistically assessed
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umber of cells migrating from explants to Matrigel decreased dra-
atically as assessed by the number of DAPI-stained cells around
GR explants (Fig. 1B). Surprisingly, simultaneous inhibition of uPA
nd uPAR almost completely suppressed the axon outgrowth from
he explants (Fig. 1A). Nevertheless cell migration from explants
as partially retained (Fig. 1B).
Thus, using the explant culture of mouse spinal ganglion in
atrigel, we demonstrated that uPA and uPAR was important for
he axonal growth and branching as well as for the neural cell
igration. Urokinase was critical for axon growth rate and cell
igration, while the urokinase receptor was important for the reg-
lation of axonal branching, their directed growth, and neural cell
igration.
.2. Blocking of uPAR stimulates neurite branching in neurons
ifferentiated from neuroblastoma Neuro 2a cells
To investigate further the effects of urokinase system on the
rowth and branching of axons, we used Neuro 2a neuroblastoma
ell line (N2a). N2a is a mouse neural crest-derived cell line that has
een widely used to study neuronal differentiation, axonal growth
nd signaling pathways due to their ability to differentiate into
eurons within a few days.gth values (length) of neurites are presented in graphs in B–D. Data are shown as
ted. The arrows point to neurites in the control and neurite branching upon uPAR
3.2.1. Expression of uPA and uPAR in Neuro 2a cells differentiated
neurons
Neuro 2a cell differentiation was  induced by cell deprivation.
First, we evaluated the expression of uPA and uPAR in the growth
cones of axons upon N2a differentiation. Double immunoﬂuores-
cence staining of N2a cells with antibodies against NF200 and uPAR
is shown in Fig. 2A. To reveal the intracellular localization of uPAR
and uPA we performed the staining with uPAR and uPA antibodies
after Triton X-100 permeabilization (Fig. 2B).
The immunoﬂuorescent assay showed that differentiated cells
expressed uPA and uPAR (Fig. 2). Positive staining of uPAR was
detected in the soma of neurons and in their axons; it is notable
that uPAR was strongly expressed in axon growth cones (shown by
the arrow in Fig. 2A, B). Urokinase expression was  detected in the
cell body and in axon growth cones as revealed by the staining after
permeabilization (shown by the arrow in Fig. 2B).
3.2.2. Neurite formation and branching depend on uPAR activity
in differentiated Neuro 2a cells
We  next tested if uPAR function is important for neurite forma-
tion, growth rate and branching. After cells adhered, uPAR blocking
antibodies were added to the cell culture media. 24 h later using a
light microscope we analyzed neurite formation in the areas where
single cells located separately not touching each other.
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Fig. 4. The effect of urokinase on Cell Index and neurite outgrowth. (A) Cell index measurement by the xCELLigence System was automatically recorded in real time. The
differentiated N2a cells were plated 10,000 cells per E-plate well. Murine uPA was added to DMEM culture media at ﬁnal concentration 10 ng/ml and DMEM containing
10  ng/ml BSA was used as a control. Cell indexes were monitored for 74 h after uPA or BSA administration. All data presented are mean values of six experiments ± SEM. Left
arrow  indicates a statistically signiﬁcant difference between the control and the uPA group after 6 h of incubation (*p < 0.05), right arrow indicates statistically signiﬁcant
differences in the cell indexes between the control and the uPA group after 35 h in culture (*p < 0.05). (B) The differentiated N2a cells were plated at 1 × 104/well in
6-well  plates. After cell adhesion, the cell culture medium was replaced by a conditioned medium containing uPA (10 ng/ml), or by control media (BSA, 10 ng/ml) or by
medium containing a uPA inhibitor (Inh, IC50 8,2 M).  After 24 h the series of microphotographs was taken at least in 6 ﬁelds of view. Arrows in the ﬁgure point to long
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Fig. 5. Urokinase increases neurite length through interaction with uPAR in N2a cells. (A) Expression of uPAR in differentiated N2a cells. RT-PCR was  carried out to evaluate the
expression of uPAR in N2a control cells, in N2a cells after transfection with shRNA-uPAR and subsequent subclonal selection (sh-uPAR), and in N2a cells after transfection with
pN1-uPAR (pN1-uPAR) with subclonal selection. The mRNA level was  normalized to -actin expression as a housekeeping gene. Reproducible results of three independent
experiments are presented. (B) Western blot analysis of uPAR content in sh-uPAR and pN1-uPAR cells. Reproducible results of three independent experiments are presented.
(C)  The uPA-dependent neurites’ outgrowth was measured in sh-uPAR, in pN1-uPAR cell cultures and in cells with native uPAR expression (“control”). The relative average
length of the neurites was  calculated using microphotographs of 6 random ﬁelds of view in each experiment. Data are shown as mean ± SEM, * indicates p < 0.05 between
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esults  of three independent experiments are presented.
uPAR blocking led to changes in neurite growth characteristics:
n increase in the average number of neurites per cell compared to
he control and in a 1.5-fold increase in neurite branching. These
esults were statistically signiﬁcant (Fig. 3, p < 0.05). uPAR blocking
ad no effect on the average neurite length of N2a cells (p  0.05).
n this study we demonstrate for the ﬁrst time that uPAR expression
n axon growth cones is essential for normal axon growth trajec-
ory, since uPAR blocking enhances neurite formation de novo and
ranching.
.2.3. Urokinase stimulates neurite outgrowth in Neuro 2a cells
Based on our data obtained ex vivo, we hypothesized that
xogenous urokinase can stimulate neurite outgrowth. Taking into
ccount the well-established fact that urokinase promotes cell
dhesion and proliferation, we assumed that uPA can also stimulate
eurite outgrowth. To prove this we used xCELLligence system.
Murine uPA was obtained from HEK293 cells, which were trans-
ected with plasmid vector for uPA expression. The conditioned
eurites formed by the cells upon uPA administration. Bars 75 m.  (C) The evaluation o
nd  neurite length (“Average length of neurite”) are presented in graphs, data are show
espectively. Reproducible results of three independent experiments are presented.nd # indicates p < 0.005 between control + uPA and pN1-uPAR + uPA. Reproducible
medium from these cells was used as a source of exogenous uPA.
We observed that during the ﬁrst 2–8 h, uPA (10 ng/ml) signiﬁcantly
decreased the cell index compared to the control (BSA, 10 ng/ml),
reﬂecting the reduced cell adhesion and spreading (left arrow in
Fig. 4A). After 35 h a statistically signiﬁcant increase in the cell index
was detected, indicating that later on urokinase had a stimulatory
effect on neurite outgrowth and increased their length (p < 0.05,
right arrow in Fig. 4A). uPA administration had no statistically sig-
niﬁcant effect on neuron proliferation (data not shown).
The results obtained with xCELLigence system were conﬁrmed
by direct calculation of the length of neurites formed by N2a
cells after administration of exogenous urokinase or selective
uPA inhibitor (Fig. 4B). After 24-h incubation, cells were ana-
lyzed and images were taken (at least 6 ﬁelds of view for each
well). The length and number of neurites was further assessed
using automated image analysis program (MetaMorph Program,
Molecular Devices, PA, USA). Fig. 4B demonstrates differentiated
N2a cells in control (BSA, 10 ng/ml) or upon exogenous urokinase
f neurite formation (“Processes in N2a cells”), branching (“Branches in neurites”)
n as mean ± SEM, * and ** indicate p < 0.05 and p < 0.01 compared to the control,
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dministration (uPA, 10 ng/ml), or in the presence of uPA inhibitor
Inh, IC50) after 24 h of incubation. uPA administration resulted in a
0% increase in the average length of outgrowing neurites (but not
he number of processes and branches) compared to the control
*, p < 0.05 in Fig. 4C), while uPA inhibitor dramatically reduced the
ength of the growing neurites (**, p < 0.01 Inh vs. control in Fig. 4C).
Thus, these results suggest that urokinase contributes sig-
iﬁcantly to the regulation of neurite growth rate, i.e.  uroki-
ase stimulates neurite outgrowth and an increase in their
ength.
.2.4. Urokinase stimulates neurite outgrowth in Neuro 2a cells
ia interaction with uPAR
Taking into consideration the results described above we
ssumed that urokinase could exert its effects on neurite outgrowth
ia interaction with its speciﬁc receptor uPAR. To conﬁrm the
ssumption, we utilized an overexpression/suppression approach.
lasmid vector encoding shRNA reduced the uPAR/mRNA level at
east 5-fold in N2a cells, while overexpression using pN1-uPAR vec-
or upregulated the uPAR/mRNA level more than 30-fold. uPAR
xpression was veriﬁed by real time PCR (Fig. 5A) and western blot
nalysis (Fig. 5B). Control N2a cells, cells overexpressing uPAR and
hRNA-uPAR cells were differentiated by 24 h deprivation before
he experiment. To test urokinase effects, cells were resuspended
n conditioned media from the control HEK293cells or HEK293 cells
roducing uPA (ﬁnal concentration 10 ng/ml).
Cells overexpressing uPAR (pN1-uPAR) demonstrated a slightly
reater average length of neurites compared to control (Fig. 5C).
n cells with suppressed uPAR (sh-uPAR) the average length of
eurites was decreased compared to control (Fig. 5C). However,
PA administration signiﬁcantly increased the rate of neurite out-
rowth in both, control cells (1.6-fold increase in control + uPA vs.
ontrol, *p < 0.05) and in cells overexpressing uPAR (2-fold increase
n pN1-uPAR + uPA cells vs. pN1-uPAR, **p < 0.01). It is notable that
he administration of uPA had no effect on neurite outgrowth in
ells with suppressed uPAR (sh-uPAR compared to sh-uPAR + uPA
ells). The data obtained on uPAR overexpressing cells upon uPA
dministration resulting in increased length of the forming neurites
ompared to control (pN1-uPAR + uPA vs. control + uPA, #p < 0.005)
onﬁrm the above assumption on the importance of uPA/uPAR
nteraction for neurite outgrowth.
Therefore, we found that uPAR blocking resulted in the
ncreased formation of neurites de novo and enhanced branching
f existing neurites. The addition of uPA promoted neurite elonga-
ion, presumably due to uPA interaction with its speciﬁc receptor
PAR in the growing axons.
.3. Blocking of uPAR in DRG explants stimulates axon branching
x vivo
Further evidence that uPA/uPAR system is essential for neurite
longation and branching as well as for neural cell migration was
btained using a 3D explant model of DRG, which were isolated
rom wild mice (WT) or from mice lacking uPA gene (KO-uPA).
urprisingly, RT-PCR data (Fig. 6A) and western blotting analy-
is demonstrated that uPAR was expressed more intensively in
O-uPA DRG than in WT  DRG (Fig. 6В, C), suggesting that the ele-
ated uPAR expression in KO-uPA DRG may  reﬂect a compensatory
echanism for the insufﬁcient uPA maintenance; however, this
peculation requires further research.
.3.1. Urokinase stimulates neural cell migration and neurites
utgrowth by uPAR in DRG explants
The role of the urokinase system in cell migration and neurite
utgrowth was investigated using DRG explants from WT  or trans-
enic KO-uPA mice, which were incubated in Matrigels with theell Biology 95 (2016) 295–310
addition of exogenous uPA (or BSA as a control) during 14 days.
The average neurite length was  analyzed on the 14th day using a
light microscope at low magniﬁcation (Fig. 7 A). Administration of
uPA signiﬁcantly stimulated the neurite outgrowth in WT  (*p < 0.05
in Fig. 7B) and KO-uPA explants (**p < 0.05 in Fig. 7B). Interest-
ingly, spontaneous neurite outgrowth in KO-uPA was  greater than
in WT  explants (***p < 0.001 in Fig. 7B) and the stimulatory effect of
uPA on neurite outgrowth was  more profound in KO-uPA explants
compared to WT  explants (WT  + uPA vs. KO-uPA + uPA, #p < 0.05 in
Fig. 7B).
Furthermore, we  evaluated the number of cells migrating from
DRG explants into Matrigels and the relative length of cell migration
paths. We  found that uPA administration signiﬁcantly stimulated
both processes: spontaneous cell migration estimated by the num-
ber of migrating cells (*, **p < 0.05 in Fig. 7C), and the relative length
of cell migration path i.e.  length of cell migration (*, ** p < 0.05 in
Fig. 7D). It is notable that in DRG from KO-uPA mice, that exhibited
the elevated uPAR expression, the stimulatory effect of urokinase
on neural cell migration was  more pronounced than in WT explants
(#, *p < 0.05 in Fig. 7B, C), similar to the effects of uPA on the
growth of neurites in DRG explants from mice lacking the uPA
gene.
These results conﬁrm our initial assumption that the stimulat-
ing effect of uPA on neural cell migration and neurite outgrowth
is mediated by the uPA interaction with its speciﬁc receptor,
uPAR.
3.3.2. uPA-uPAR system affects axon growth trajectory in DRG
explants of transgenic mice
To further conﬁrm our hypothesis that uPAR is involved in
the growth and branching of axons, we used uPAR blocking
antibodies that were mixed with Matrigels before placing the gan-
glia into the three-dimensional culture. We  used DRGs from wild
type mice (WT) and from mice lacking urokinase (KO-uPA). We
expected that, due to the elevated expression level of uPAR in KO-
uPA mice, the effect of the receptor blocking on neurite outgrowth
would be more pronounced in the case of DRG from KO-uPA mice
compared to control (WT).
After 14 days in culture, the DRG explants were stained with
DAPI and antibody recognizing axons (NF200). Fig. 8 shows the con-
focal images of a three-dimensional immunoﬂuorescence staining
of DRG explants. It appeared that, indeed, blocking the urokinase
receptor in ganglia explants from KO-uPA mice resulted in more
profound adverse effects on the axon growth trajectory compared
to axons growing from DRGs of wild type mice. Supplementary
materials contain videos of stereomicroscopy images obtained
using 3D DRG explants and are presented in Fig. 8 (Video S5 and S6
in the online version at DOI: 10.1016/j.ejcb.2016.05.003).
4. Discussion
Growth cones of regenerating peripheral neurons have to
migrate through a structurally altered injury site, through inﬁl-
trating cells and modiﬁed extracellular matrix, along residual basal
lamina to reinnervate their synaptic targets. To promote migra-
tion, growth cones have to secrete proteases that degrade cell–cell
and cell-matrix adhesion contacts. Potential means for the growth
cones would be the use of proteases, such as plasminogen activators
that are capable of activating other proteases, degrading extracel-
lular matrix and destroying adhesive contacts, thus promoting the
axonal outgrowth. Plasminogen activators cleave the proenzyme
plasminogen to its active form plasmin that has a broad range of
substrates, including the neural cell adhesion molecule NCAM in
the nervous system (Endo et al., 1998).
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Fig. 6. uPAR expression in DRG. (A) The uPAR mRNA content in DGR explants from wild type mice (WT) and from uPA-deﬁcient mice (KO-uPA) was  evaluated using RT-PCR.
Agarose  gel electrophoresis after RT-PCR was  carried out to verify the production of a single gene-speciﬁc product in each sample (uPAR gene (151 bp) and -actin (112 bp)).
1,  17—DNA ladder; 2–4—probes containing WT DNA template and uPAR primers; 5–7—probes containing KO-uPA DNA template and uPAR primers; 8–10—probes containing
WT  DNA template and -actin primers; 11–13—probes containing KO-uPA DNA template and -actin primers; 14–15—negative control containing uPAR primers without
DNA  template; 16-—negative control containing -actin primers without DNA template. (B) mRNA level of uPAR in DRG explants from WT and KO-uPA mice. The mRNA
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It was suggested that plasminogen activators could play an
mportant role in facilitating axon extension and cell migra-
ion during the development and regeneration of the peripheral
ervous system (Pittman, 1985; Pittman et al., 1989; McGuire and
eeds, 1990; Hayden and Seeds, 1996). However, data on the poten-
ial function that the uPA/uPAR system can perform in peripheral
erves are obscure. Expression and secretion of plasminogen acti-
ators were shown to be upregulated in regenerating mammalian
ensory neurons in culture (Seeds et al., 1996). The addition of
lasminogen activators or plasminogen inhibitors to cultured neu-
ons had profound effects on neurite outgrowth and cell migration
Hawkins and Seeds, 1989). In mice, after sciatic nerve crush there
as an induction of mRNAs of several plasminogen activators in the
ensory neurons contributing to the regeneration of the crushed
erve compared to their sham counterparts (Siconolﬁ and Seeds,
001). The uPA-uPAR system was also shown to be involved in neu-
al cell differentiation, since uPAR blocking with antibody inhibited
he morphological and biochemical differentiation of PC12 cells
nduced by nerve growth factor NGF (Farias-Eisner et al., 2000).
In the present study, we demonstrated for the ﬁrst time the
ssential role of uPA and uPAR in the initiation, elongation and
ranching of neurites. Using 3D explant culture of mouse spinal
anglia, we show that uPA and uPAR were involved in the reg-
lation of axonal growth and branching as well as in neural cell
igration (Figs. 1 and 7).ean ± SEM, N = 3, * p < 0.05. (C) Western blot analysis of uPAR expression in DRGs
 presented. (D) Densitometry analysis of western blots results. Data are shown as
uPA exerted its effect on cell migration and neurite outgrowth
via interaction with uPAR (Figs. 5C and 7). We  conﬁrmed this data
in vitro using Neuro 2A cell culture (Figs. 4 and 5C). uPA inhibi-
tion suppressed neural cell migration and signiﬁcantly abrogated
axon growth rate and growth trajectory, both ex vivo (Fig. 1) and
in vitro (Fig. 4), suggesting that urokinase proteolytic activity upon
its interaction with uPAR is essential for these processes. However,
he uPAR expression level was important for uPA-dependent stim-
ulation of axon growth and cell migration, since in contrast to WT
mice, in KO-uPA mice that exhibit elevated uPAR expression level
in ganglia we  observed an increased axon growth rate and neural
cell migration in response to uPA administration (Fig. 7).
One would expect that blocking of uPA and uPAR interaction
would affect neurite outgrowth and cell migration and the obtained
data were unexpected. Indeed, uPAR blocking suppressed neu-
ral cell migration (Fig. 1) while in neurons it caused changes in
cell morphology, i.e.  an increased number of neurites and their
enhanced branching (Figs. 3 and 8). Moreover, in KO-uPA mice that
lacked urokinase but had an elevated level of uPAR, the observed
spontaneously higher rate of neurite outgrowth suggested that
uPA could be not the only ligand of uPAR (Fig. 7). It is well
known that uPA can exhibit physiological effects that are inde-
pendent of uPAR binding, while the uPAR function can engage
multiple ligands (vitronectin, Endo180, integrins and SRPX2) (Lino
et al., 2014; Engelholm et al., 2003; Wienke et al., 2007; Mad-
sen et al., 2007; Royer-Zemmour et al., 2008; Franco et al., 2006).
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Fig. 7. uPA-uPAR interaction stimulates neurites outgrowth and neural cell migration in DGR explants. (A) DRG explants from wild type mice (WT) and mice with knockout
uPA  gene (KO-uPA) were cultured in the presence of uPA (10 ng/ml) or control media (BSA 10 ng/ml) for 14 days. Explants were visualized using darkﬁeld microscopy at low
magniﬁcation. Bars 300 m.  Reproducible results of three independent experiments are presented; each experiment comprises WT  and KO-uPA group (4 mice in each group).
(B)  Calculation of the average length of neurites emerging from DGRs into Matrigels; *, p < 0.05 between WT + uPA and WT  + BSA; **, p < 0.05 between KO-uPA + uPA and
KO-uPA + BSA; *** p < 0.001 between KO-uPA + BSA and WT + BSA; # p < 0.05 between KO-uPA + uPA and WT + uPA. Reproducible results of three independent experiments
are  presented; each experiment included results from the control and the KO-uPA group (4 mice in each group). (C) DRG explants from wild type mice (WT) and mice with
knockout uPA gene (KO-uPA) were cultured in the presence of uPA (10 ng/ml) or control media (BSA 10 ng/ml) during 14 days. The nuclei of migrated cells from DRG to the
Matrigel were counterstained with DAPI. Dotted line indicates the border of DRG, arrows indicates the migration path of cells. Bars 300 m.  (D) Counting the number of
E. Semina et al. / European Journal of Cell Biology 95 (2016) 295–310 307
c
(
iFig. 7. (Cont
ells that migrated from DGR to Matrigels (*, **, #p < 0.05). Reproducible results from thr
4  mice were included in each group). (E) Evaluation of the average length of the cell mig
ndependent experiments are presented; each experiment includes WT and KO-uPA grouinued)
ee independent experiments using WT or KO-uPA group of animals are presented
ration path from DGRs into Matrigels (*, **, p < 0.05). Reproducible results of three
p (4 mice in each group).
308 E. Semina et al. / European Journal of Cell Biology 95 (2016) 295–310
Fig. 8. uPAR blocking impairs axonal growth from DRG explants. DGR from wild type mice (WT) and mice lacking uPA gene (KO-uPA) were cultured in Matrigels containing
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pon binding to uPAR, uPA can function as a protease that
egrades the extracellular matrix thus facilitating the migration
f vascular cells (Blasi and Sidenius, 2010; Blasi and Carmeliet,
002) and neural cells (Figs. 1 and 7). However, uPAR itself can
unction uPA-independently (Blasi and Sidenius, 2010; Blasi and
armeliet, 2002). In the present study we describe the effects of
PAR on neuron morphology. We  suggest that uPAR may  function
PA-independently and these effects could be attributed to uPAR
nteraction with alternative ligands in the nervous system.
The assumption that uPAR could be involved in neuronal differ-
ntiation is supported by data on uPAR knockout mice. uPAR null
uPAR-/-) mice lack parvalbumin-containing GABA-interneurons
eurons and are characterized by abnormalities in the developing
rain cortex which are associated with increased susceptibil-
ty to spontaneous and chemically-induced seizures and with
ncreased anxiety and impaired social interactions (Bruneau and
zepetowski, 2011; Royer-Zemmour et al., 2008). This phenotype
as observed only in uPAR-/- mice, but not in uPA-/- mice, which
uggests the presence of an alternative ligand of uPAR with other
unctions in the central nervous system. Recent studies indicate
hat Sushi repeat protein, X-linked 2 (SRPX2) interacts with uPAR,
nd inhibition of SRPX2 interaction with uPAR results in an uPAR-/-
like phenotype (Royer-Zemmour et al., 2008; Franco et al., 2006).
In axons, the appropriate interaction of cell adhesion molecules
ith extracellular matrix is crucial for development of nervous sys-
em. Axon growth and polarization during neurogenesis is highly
ependent upon the assembly of integrin complexes. Integrins have
een implicated in uPA/uPAR-dependent activation of cell adhesion
nd cell morphology changes in non-neuronal systems (Blasi and
armeliet, 2002; Blasi and Sidenius, 2010; Carmeliet, 2003; Franco
t al., 2006; Wei  et al., 2001; Wei  et al., 1996), but little is known
bout uPAR-integrins’ interaction in neurons. It has been suggested
hat cooperation of uPAR and / integrin heterodimers is neces-
ary for uPA-dependent neuron migration and neuritogenesis (Lino
t al., 2014). It is tempting to speculate that the uPA/uPAR system,
nd particular uPAR, can exert its effects on the formation and regu-
ation of axon branching via interaction with the integrin complex.
owever, this assumption needs further investigation.
To further investigate the role of uPA/uPAR in the neural cell
igration, growth and axon branching we utilized 3D explant DRGtibody against NF200 for axon visualization. The nuclei were counterstained with
ing (arrows in the ﬁgure). Bars 300 m. Reproducible results of three independent
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cultures from wild type and uPA-deﬁcient mice. Administration
of exogenous uPA signiﬁcantly stimulated neurite outgrowth from
both, the WT  and KO-uPA DRGs. It is notable that uPAR expression
in ganglia from KO-uPA mice was  elevated, compared to the WT
mice, and that the spontaneous neurite formation (neurite length)
in KO-uPA explants was higher than in WT DRGs, probably due to
the elevated uPAR expression. Administration of uPA resulted in the
signiﬁcant stimulation of neurite outgrowth and neural cell migra-
tion from DRG of KO-uPA mice compared to the WT.  Moreover,
uPAR blocking dramatically affected the axonal growth pattern
from DRG of KO-uPA mice compared to WT  ganglia and resulted
in axonal trajectory distortion. Similar effects were obtained on
neural cell migration from WT  and KO-uPA DRGs. The described
results indicate that the urokinase system contributes signiﬁcantly
to neural cell migration and neuron morphology, and affects the
initiation, elongation and branching of neurites.
5. Conclusion
In the present study we describe the essential role of the uPA and
uPAR in axonal growth and branching, and in neural cell migration.
The suppression of endogenous urokinase substantially abrogated
the axonal growth by decreasing the length of axons and their total
number as well as by distorting their normal growth trajectory.
Moreover, uPA inhibition signiﬁcantly reduced the rate and the
number of cells migrating from DRG explants into Matrigels. Inhi-
bition of uPA-uPAR interaction by anti-uPAR antibody resulted in a
dramatic reduction of the total number of growing axons and the
number of cells migrating from DRG explants into Matrigels. This
was also characterized by alterations in the trajectory of the grow-
ing axons and their increased branching. Inhibition of both, uPA
and uPAR, almost totally blocked the growth of axons from DRG
explants.
It is notable that uPAR expression in ganglia obtained from
mice lacking uPA (KO-uPA) was signiﬁcantly increased compared
to control (WT  mice). The length of neurites in DRG explant cul-
ture from KO-uPA mice was  greater than in control DRGs, which
may  be due to the elevated uPAR expression. Administration of
uPA resulted in pronounced stimulation of neurite outgrowth and
neural cell migration from DRG of KO-uPA mice compared to the
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Using Neuro 2a cells differentiated into neurons, we found that
locking uPA/uPAR interactions by using uPAR-blocking antibod-
es stimulated neurite formation and enhanced the branching of
re-existing neurites. The addition of uPA stimulated the elon-
ation of neurites, most likely via the interaction of uPA with its
peciﬁc receptor uPAR located on the growth cones of axons. Based
n the results obtained in this study, we suppose that uPA stimu-
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